Hollo Platform - accessible AI technology for mental healthcare for those facing mental illnesses

Hollo DigiACT for Cancer Patients (只提供英文版本)

Hollo’s DigiACT solution is focused on alleviating depression and anxiety symptoms in Cancer Patients through Digital Therapeutics. By using evidence-based Acceptance Commitment Therapy through games and interactive content, Hollo’s product helps Cancer patients (and in the future, chronic patients), overcome symptoms of depression and anxiety.

June 2022

Investigating the Cancer Patient Journey with Empathy

Our team collaborated with MAKE Studios, an amazing design thinking studio to breakdown the journey a cancer patient may go through in our local market. We highlighted several key pain points, whether it was an emotional burden, financial, social, etc. We had interviewed several Cancer patients and were able to find great insights.

September 2022

Designing a rewarding and sticky digital therapy

Taking the prospective prototypes and key user personas from MAKE’s investigation, Hollo worked with Press Start Hong Kong on understanding how to best create value for our patients with our Digital Intervention. Taking key principles in gamification to ultimately have a lasting impact on our patients, we implemented key ideas like rewards, visible and tangible progression, splitting content into levels and several game mechanisms that work well on mobile.

October 2022

Diving deep into development

Taking our carefully designed games and exercises to our partners Sparkmate to bring it to life. Coordinating with Morgan and his team to create an Agile development focused on serving our minimal viable product for our upcoming Clinical Trial. This trial focuses on the first iteration of our intervention and will inform our future developments, taking this intervention to market as we continue to improve it.